语言版本

Time of issue:2021-09-02 16:56:33

中文 English





搜索

Search





Homepage

/

About us

/

News

/

The API Fulvestrant of Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. has been changed to status "A" at the Center for Drug Evaluation (CDE) (date of update: Jan. 23, 2026).

All categories



The API Fulvestrant of Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. has been changed to status "A" at the Center for Drug Evaluation (CDE) (date of update: Jan. 23, 2026).

Categories:News
Author:
Origin:
Time of issue:2026-05-09 14:28
Views:0

(Summary description)The API Fulvestrant of Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. has been changed to status "A" at the Center for Drug Evaluation (CDE) (date of update: Jan. 23, 2026).

The API Fulvestrant of Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. has been changed to status "A" at the Center for Drug Evaluation (CDE) (date of update: Jan. 23, 2026).

(Summary description)The API Fulvestrant of Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. has been changed to status "A" at the Center for Drug Evaluation (CDE) (date of update: Jan. 23, 2026).

Categories:News
Author:
Origin:
Time of issue:2026-05-09 14:28
Views:0

Information

The API Fulvestrant of Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. has been changed to status "A" at the Center for Drug Evaluation (CDE) (date of update: Jan. 23, 2026).

Scan the QR code to read on your phone

Previous: Fulvestrant has received a Certification of Suitability (CEP) (date of issuance: May 4, 2026).

Next: The API Calcipotriol of Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. has been changed to status "A" at the Center for Drug Evaluation (CDE) (date of update: Jan. 27, 2026).

Previous: Fulvestrant has received a Certification of Suitability (CEP) (date of issuance: May 4, 2026).

Next: The API Calcipotriol of Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. has been changed to status "A" at the Center for Drug Evaluation (CDE) (date of update: Jan. 27, 2026).